Cargando…
Inhalation of a Short-Acting β(2)-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects
BACKGROUND: Catecholamine infusion elicits an increase in clotting factors and this increase has been attributed to stimulation of β(2)-adrenorecptors (β2AR). Accordingly, we tested the hypothesis that inhalation of a short-acting selective β2AR agonist can induce a procoagulant state in healthy ind...
Autores principales: | Ali-Saleh, Mais, Sarig, Galit, Ablin, Jacob N., Brenner, Benjamin, Jacob, Giris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933351/ https://www.ncbi.nlm.nih.gov/pubmed/27379911 http://dx.doi.org/10.1371/journal.pone.0158652 |
Ejemplares similares
-
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β(2)-adrenoreceptor agonist (uLABA)
por: Bjermer, Leif, et al.
Publicado: (2015) -
Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist
por: Roig, Jorge, et al.
Publicado: (2009) -
Cardiovascular Autonomic Profile in Women With Premenstrual Syndrome
por: Koifman, Rimma, et al.
Publicado: (2018) -
Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023) -
Self-Reported Childhood Maltreatment and Traumatic Events among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis
por: Hellou, Raneen, et al.
Publicado: (2017)